Updates are available Correction dated 2020-10-29
Click to view Correction: https://doi.org/10.1038/s41551-020-00652-2
-
Authors
Suh, Susie http://orcid.org/0000-0002-4921-1429
Choi, Elliot H.
Leinonen, Henri http://orcid.org/0000-0002-0388-832X
Foik, Andrzej T. http://orcid.org/0000-0003-1110-9223
Newby, Gregory A.
Yeh, Wei-Hsi http://orcid.org/0000-0001-7507-8177
Dong, Zhiqian
Kiser, Philip D. http://orcid.org/0000-0003-1184-9539
Lyon, David C. http://orcid.org/0000-0002-4367-5636
Liu, David R. http://orcid.org/0000-0002-9943-7557
Palczewski, Krzysztof http://orcid.org/0000-0002-0788-545X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (T32EY024236, F30EY029136, EY009339, EY027283, EY025451, EY019312)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM007250, T32GM007250, T32GM008803)
Fight for Sight, Eye and Tissue Bank Foundation, The Finnish Cultural Foundation, Orion Research Foundation
Howard Hughes Medical Institute
Department of Veterans Affairs | Office of Academic Affiliations, Department of Veterans Affairs (I01BX004939)
Research to Prevent Blindness
- License Information
-
More Information
Article History
Received: 4 February 2020
Accepted: 17 September 2020
First Online: 19 October 2020
Change Date: 12 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-020-00652-2
Competing interests
: D.R.L. is a consultant and co-founder of Beam Therapeutics, Prime Medicine, Editas Medicine and Pairwise Plants, companies that use genome editing.
